2021 first-half earnings
- Half-year revenue growth of +131% (+124% at current exchange rates), with a stable level of losses despite the ramping up of investments
- Financial structure further strengthened with the €35m of funds raised (net of issue costs) through the initial public offering in
July 2021 - Delayed ramp-up of R&D and additional needs of customers for the industrialisation of XpertEye within their organisations generating a growth gap and a revision of the guidance for 2021-2022
Unaudited consolidated earnings - IFRS (€’000) | First half of 2021 | First half of 2020 | Change |
Revenues | 3,935 | 1,754 | +124% |
Adjusted gross margin1 % of revenues | 2350 59.7% | 1020 58.2% | +130% +1.5pts |
Staff costs | (4,622) | (3,363) | +37% |
Adjusted EBITDA2 | (2,276) | (2,402) | +5% |
EBIT | (3,700) | (3,602) | -3% |
Financial income (expense) | (230) | (92) | -150% |
Income from ordinary operations before tax | (3,930) | (3,694) | -6% |
Consolidated net income | (3,202) | (3,502) | +9% |
2021 first-half earnings: level of loss stable despite the ramping up of investments
For the first half of 2021, the AMA Group recorded €3.9m of revenues, up from €1.7m for the first half of 2020, with 124% growth at current exchange rates (+131% at constant exchange rates). AMA benefited from the robust development of its client portfolio, with both its longstanding clients (84% of growth) and the acquisition of 91 new clients during the first half of this year. The Group ramped up its signing of master agreements and set up its first strategic commercial partnerships in
The Group’s gross margin came to €2.3m for the first half of 2021, with a margin rate of 59.7%, a 1.5-point improvement thanks to strong growth in software sales (+275%), which represent 29% of the Group’s revenues for the period.
The strong progress with sales and the improvement in the gross margin during the first half of the year limited the operating loss to €(3.7)m, compared with €(3.6)m for the first half of 2020, offsetting to a great extent the increase in staff costs (+€1.3m). After €(0.2)m of financial income and expenses and €0.7m of tax income, the AMA Group’s consolidated net income came to €(3.2)m.
Financial structure further strengthened with the €35m of net funds raised through the initial public offering in
At
R&D ramp-up extended and additional client requirements for the industrialisation of XpertEye within their organisations, reflected in a growth gap and revised guidance for 2021-2022
AMA is currently working to meet the technological challenges relating to the integration and interoperability of its new applications within its clients’ information systems and their additional needs. Under these conditions, the industrialisation of XpertEye within major groups is being held back. Based on the action plan drawn up, the Group has revised its product roadmap and its revenue assumptions for 2021 and 2022.
This step is vital to ensure the performance of AMA’s open, multi-platform solution, securing its future margins and growth. The Group has also continued to further strengthen its positions with its existing clients and to bring new clients on board: at
By the end of October, AMA had met 78% of its recruitment targets. The Group has integrated 66 new staff since the start of the year, taking its headcount up to 186.
AMA recorded unaudited consolidated revenues of €1.3m for the third quarter (-18% versus Q3 2020), against the backdrop of a market deterioration linked to the supply chain and production pressures affecting many major industrial firms. For the first nine months of 2021, growth came to 61%, with revenues of €5.3m.
AMA now expects 2021 revenues to reach at least €6.5m, compared with €15.4m initially. AMA will adapt the pace of its sales force recruitment drive over the next few months in order to realign its organisation. AMA expects to see a return to sustained growth from the second half of 2022, driven by the completion of its R&D work enabling the industrial-scale deployment of its solutions and the ramping up of its commercial strategy.
Half-year financial report
AMA Corporation PLC’s financial report for the first half of 2021 was published on
Next date: 2021 fourth-quarter and full-year revenues:
Disclaimer
This press release contains certain non-factual elements, including but not restricted to certain statements concerning its future results and other future events. These statements are based on the current vision and assumptions of AMA Corporation PLC’s leadership team. They include various known and unknown uncertainties and risks that could result in material differences in relation to the expected results, profitability and events. In addition,
About AMA
Whereas most collaborative working tools quickly reach their limits once outside the office space, AMA enables experts to work remotely with frontline workers using a secure software platform combined with video tools that are perfectly tailored to each business.
With nearly seven years’ experience in remote assistance solutions, AMA helps industry and service providers of all sizes, as well as medical establishments, to accelerate their digital transformation. Deployed in more than 100 countries, AMA’s assisted reality platform, XpertEye, addresses a wide range of use cases, from remote diagnostics to inspection, planning and workflow management. Its unique solutions for remote interactive collaboration enable businesses and institutions to increase productivity, speed up resolution times and maximise uptime.
AMA is a fast-growing company with offices in
Contacts
Sonia Papillon
Investor and Analyst Relations
+33 (0)6 70 45 73 41
investors@ama.bzh
Financial Media Relations
Calyptus -
+33 (0)6 09 68 55 38
ama@calyptus.net
APPENDICES
Unaudited first-half earnings, approved by the Board of Directors on
The financial statements at 30 June do not take into account the €35m capital increase (net of issue costs) carried out with settlement-delivery on
Condensed half-year income statement
IFRS (€’000) | H1 2021 | H1 2020 |
Revenues | 3,935 | 1,754 |
Purchases consumed | (1,418) | (450) |
Other income | 1,997 | 1,084 |
Other purchases and external expenses | (1,950) | (1,345) |
Staff costs | (4,622) | (3,363) |
Depreciation of property, plant and equipment and intangible assets | (1,423) | (1,179) |
Other expenses | (219) | (104) |
EBIT | (3,700) | (3,603) |
Financial income | 33 | 8 |
Financial expenses | (263) | (100) |
Net financial income (expense) | (230) | (92) |
Pre-tax income | (3,930) | (3,694) |
Corporate income tax income | 728 | 192 |
Net income for the period | (3,202) | (3,502) |
Earnings for the period attributable to owners of the parent | (2,847) | (3,658) |
Non-controlling interests | (355) | (155) |
Quarterly revenues
Quarterly revenues - IFRS (€’000) | 2021 | 2020 | Change |
First quarter | 2,175 | 548 | 297% |
Second quarter | 1,848 | 1,196 | 55% |
Third quarter | 1,272 | 1,542 | -18% |
Condensed half-year balance sheet
IFRS (€’000) | H1 2021 | H1 2020 |
Property, plant and equipment | 1,352 | 832 |
Intangible assets | 6,607 | 5,461 |
Rights of use | 1,648 | 1,110 |
Financial assets | 129 | 108 |
Deferred tax assets | 1,276 | 504 |
Non-current assets | 11,012 | 8,014 |
Inventories | 1,634 | 1,661 |
Current tax receivables | 142 | |
Trade and other receivables | 2,646 | 3,672 |
Other current assets | 2,816 | 1,834 |
Cash and cash equivalents | 2,001 | 2,368 |
Current assets | 9,239 | 9,535 |
Total assets | 20,251 | 17,549 |
Share capital | 2,427 | 6,245 |
Issue premiums | ||
Translation reserves | 49 | 40 |
Retained earnings | (3,000) | 500 |
Equity attributable to owners of the parent | (524) | 6,785 |
Non-controlling interests | (772) | (745) |
Total shareholders’ equity | (1,296) | 6,040 |
Borrowings and financial debt | 1,765 | 2,397 |
Lease liabilities | 1,108 | 675 |
Defined benefit plan liabilities | 175 | 171 |
Provisions | ||
Other liabilities | ||
Deferred tax liabilities | 3 | 2 |
Non-current liabilities | 3,051 | 3,245 |
Bank overdrafts | 5,877 | 1,128 |
Current tax liabilities | 149 | 46 |
Borrowings and financial debt | 4,707 | 1,321 |
Lease liabilities | 549 | 449 |
Trade and other payables | 2,714 | 974 |
Client contract liabilities (deferred income) | 2,217 | 2,487 |
Provisions | 538 | 538 |
Other liabilities | 1,747 | 1,324 |
Current liabilities | 18,498 | 8,267 |
Total liabilities | 21,548 | 11,511 |
Total shareholders’ equity and liabilities | 20,251 | 17,550 |
Half-year cash-flow statement
IFRS (€’000) | H1 2021 | H1 2020 |
Net income for the period | (3,202) | (3,502) |
Adjustments for: | ||
Depreciation of property, plant and equipment | 665 | 594 |
Depreciation of intangible assets | 758 | 585 |
Net financial income (expense) | 230 | 92 |
Income from disposal of property, plant and equipment | 41 | 2 |
Cost of share-based payments | 1 | 21 |
Corporate income tax income | (728) | (192) |
Other items | 6 | (9) |
Total adjustments | 972 | 1,092 |
Total operating cash flow | (2,330) | (2,410) |
Change in: | ||
Inventories | (115) | (825) |
Trade and other receivables | 902 | (1,235) |
Contract liabilities | (300) | 1,178 |
Advances and deposits | 54 | 45 |
Trade and other payables | 1,725 | (16) |
Employee benefits and provisions | 26 | 30 |
Other current receivables / payables | (1,666) | 4 |
Other working capital requirement items | 740 | 6 |
Total changes | 625 | (819) |
Cash flow from operating activities | (1,604) | (3,229) |
Tax paid | (89) | 333 |
Net cash from operating activities | (1,693) | (2,896) |
Acquisition of property, plant and equipment and intangible assets | (1,909) | (574) |
Income from disposal of property, plant and equipment and intangible assets | 7 | 17 |
Capitalised development costs | (1,861) | (1,064) |
Investment subsidies (incl. research tax credit offsetting capitalised costs) | 121 | 124 |
Increase in financial assets | (35) | (36) |
Decrease in financial assets | 14 | 2 |
Interest received | - | - |
Net cash from investment activities | (3,663) | (1,531) |
Capital increase | - | - |
Receipts from new borrowings and financial debt | 982 | 432 |
Receipts from lease liabilities | 1,097 | 247 |
Repayment of borrowings and financial debt | (1,421) | (174) |
Payment of lease liabilities | (369) | (258) |
Interest paid on borrowings and current accounts | (70) | (56) |
Interest paid on lease liabilities | (7) | (7) |
Net cash from financing activities | 212 | 184 |
Net change in cash and cash equivalents | (5,144) | (4,243) |
Cash and cash equivalents at 1 January | 1,240 | 2,342 |
Impact of the change in exchange rates on cash held | 28 | (27) |
Cash and cash equivalents at 30 June | (3,876) | (1,928) |
1 The adjusted gross margin corresponds to the margin on purchases consumed excluding the depreciation of inventory.
2 Adjusted EBITDA corresponds to EBIT + depreciation of property, plant and equipment and intangible assets + share-based payments in accordance with IFRS 2.
Attachment
- AMA_CP_S1-2021_EN
© OMX, source